Free Trial

Lexaria Bioscience (LEXXW) Competitors

$0.15 +0.00 (+2.04%)
As of 07/3/2025 11:00 AM Eastern

LEXXW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Lexaria Bioscience stock or one of its competitors? The main competitors of Lexaria Bioscience include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Lexaria Bioscience vs. Its Competitors

Lexaria Bioscience (NASDAQ:LEXXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends.

In the previous week, Lexaria Bioscience's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Lexaria Bioscience Neutral
180 Life Sciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lexaria Bioscience$525.92KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Lexaria BioscienceN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

Lexaria Bioscience beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Lexaria Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for LEXXW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LEXXW vs. The Competition

MetricLexaria BioscienceBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$127.96M$5.56B$9.05B
Dividend YieldN/A3.74%5.24%3.99%
P/E RatioN/A3.4027.6520.23
Price / SalesN/A4,084.30419.56119.26
Price / CashN/A13.1926.2128.59
Price / BookN/A42.828.035.65
Net IncomeN/A-$92.79M$3.18B$249.15M
7 Day Performance36.36%2.49%2.93%3.28%
1 Month Performance-34.78%2.58%1.72%3.95%
1 Year Performance-87.39%181.40%34.39%20.98%

Lexaria Bioscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LEXXW
Lexaria Bioscience
N/A$0.15
+2.0%
N/A-87.4%$0.00$525.92K0.007Gap Up
ATNFW
180 Life Sciences
N/A$0.01
-1.2%
N/A-6.9%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/A-80.9%$0.00N/A0.002
AIMDW
Ainos
N/A$0.13
-21.0%
N/AN/A$0.00$106.21K0.0040Gap Up
ALVOW
Alvotech
N/A$1.73
+1.8%
N/A-41.9%$0.00$585.60M0.004
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
+6.5%
N/AN/A$0.00N/A0.0015Gap Up
BFRIW
Biofrontera
N/A$0.09
-1.1%
N/A+200.3%$0.00$38.00M0.0070Gap Down
BTMDW
biote
N/A$0.02
-10.2%
N/A-97.5%$0.00$199.38M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.07
+13.4%
N/A-70.6%$0.00N/A0.008Gap Down

Related Companies and Tools


This page (NASDAQ:LEXXW) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners